Although there are existing AKI-related biomarkers such as neutrophil gelatinase-associated lipocalin and cystatin C that can indicate changes in renal function during the early stages of AKI, their limited availability and detection methods have hindered widespread application in clinical practice. Here, LCN2 is linked to acute kidney injury.